HOXA9 and acute myeloid leukemia: In acute myeloid leukemia (AML), it has been reported that the degradation of RBM39 represses cassette exon inclusion and promotes intron retention within mRNAs encoding HOXA9 targets and in other RNA-binding proteins (RBPs) preferentially required for AML survival6.